Saturday, March 18, 2017 8:19:56 AM
http://otcshortreport.com/?index=CNBX&action=view
1.2Mil of the 14Mil share FLOAT is SHORT
http://shortsqueeze.com/?symbol=Cnbx&submit=Short+Quote%E2%84%A2
THE RISK FACTORS IN THE 10K WERE ALREADY SATISFIED. IF YOU READ THE MOST RECENT 10Q, THEY ALREADY RAISED ANOTHER $500K ON JANUARY 7TH AND ONLY NEEDEE 1 MILLION FOR THE ENTIRE YEAR <2017>
The Company MOST likely SOLD another 500k shares since January 7th, netting them another $1.5 million , which will remove any Going Concern reflected in the 2016 10K which was before the stock ran and pretty much OBSOLETE at this point.
SHORT SELLERS WANT TO POINT TO OBSOLETE INFORMATION TO CONVINCE OR SCARE PEOPLE INTO SELLING THERE SHARES. BIG NEWS COMING, ON THE DIAGNOSTIC TESTS AND PHASE 3 TRIAL
CNBX PHASE 3 TRIAL Official Cannabics Capsules as Treatment to Improve Cancer Related Cachexia and Anorexia Syndrome in Advanced Cancer
https://clinicaltrials.gov/ct2/show/NCT02359123
CNBX READ THIS. SEE THE LINK BELOW. IMPRESSIVE! Cannabics Pharmaceuticals Announces Initial Commercialization of Cannabinoids-based Personalized Diagnostics for Cancer Patients
http://www.bizjournals.com/prnewswire/press_releases/2017/02/06/LN05175
CNBX Commercialization will commence in March 2017, when 10 first patients' liquid biopsies will be tested using this technology. The company plans to make this service available to cancer patients in Canada, Europe and the USA, under local medical cannabis regulations in each country and state, by the end of the year. Itamar Borochov, CEO of Cannabics Pharmaceuticals, says "We are the first company in the world to offer cancer patients personalized cannabinoid anti-tumor diagnostics. We are excited to be pioneers in the nexus of cannabis and personalized cancer treatments".
http://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-announces-initial-commercialization-of-cannabinoids-based-personalized-diagnostics-for-cancer-patients-300403359.html
A Hard Look at Cannabics Pharmaceuticals Inc $CNBX
http://oracledispatch.com/2017/03/13/hard-look-cannabics-pharmaceuticals-inc-otcmktscnbx/
Recent CNBX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/15/2024 02:58:24 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:27:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 03:13:35 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM